Eun-Gyoung Hong
Overview
Explore the profile of Eun-Gyoung Hong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
1337
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Choe H, Choi Y, Ha Y, Kim J, Kim M, Cha H, et al.
J Clin Endocrinol Metab
. 2025 Jan;
PMID: 39842874
Context: Thyroid hormones play a crucial role in metabolic regulation and maintaining cardiovascular homeostasis. The Parametric Thyroid Feedback Quantile-based Index (PTFQI) assesses central thyroid hormone sensitivity by standardizing the inverse...
2.
Kwak M, Baek J, Park S, Jung H, Lee E, Jang I, et al.
J Clin Endocrinol Metab
. 2024 Dec;
PMID: 39719148
Context: Experimental evidence indicates that resistin, an adipokine, negatively impacts muscle metabolism by hindering myogenesis. Objective: To explore resistin's potential as a biomarker of muscle health in humans by examining...
3.
Kim N, Lee J, Chon S, Yu J, Jeong I, Lim S, et al.
Endocrinol Metab (Seoul)
. 2024 Aug;
39(5):722-731.
PMID: 39174014
Backgruound: Atherogenic dyslipidemia, which is frequently associated with type 2 diabetes (T2D) and insulin resistance, contributes to the development of vascular complications. Statin therapy is the primary approach to dyslipidemia...
4.
Hong E, Min K, Lim J, Ahn K, Ahn C, Yu J, et al.
Adv Ther
. 2024 Mar;
41(5):1967-1982.
PMID: 38512540
Introduction: The TOujeo BEyond glucose control (TOBE) study evaluated clinical outcomes with insulin glargine 300 units/mL (Gla-300) in insulin-naïve Korean people with type 2 diabetes mellitus (T2DM) in a real-world...
5.
Sohn T, Han K, Kim Y, Lee B, Chon S, Jeong I, et al.
Diabetes Obes Metab
. 2024 Mar;
26(6):2248-2256.
PMID: 38456558
Aim: To evaluate the long-term safety and efficacy of enavogliflozin 0.3 mg/day added to metformin in patients with type 2 diabetes mellitus. Materials And Methods: After 24 weeks of a...
6.
Heo J, Han K, Hong J, Seo H, Hong E, Yu J, et al.
Diabetes Metab J
. 2024 Feb;
48(5):937-948.
PMID: 38310875
Backgruound: This study assessed the efficacy and safety of triple therapy with pioglitazone 15 mg add-on versus placebo in patients with type 2 diabetes mellitus (T2DM) inadequately controlled with metformin...
7.
Choi K, Kim T, Chon Y, Kim M, Lee J, Hwang S, et al.
J Cachexia Sarcopenia Muscle
. 2023 Oct;
14(6):2747-2756.
PMID: 37881112
Background: We examined the incidence and predictors of clinical outcomes in metabolic dysfunction-associated fatty liver disease (MAFLD), focusing on anthropometric parameters. Methods: Adult patients with MAFLD were identified in nationwide...
8.
Moon J, Park I, Kim H, Chung C, Won K, Han K, et al.
Diabetes Metab J
. 2023 Sep;
47(6):808-817.
PMID: 37750183
Backgruound: This study investigates the long-term efficacy and safety of evogliptin add-on therapy in patients with inadequately controlled type 2 diabetes mellitus (T2DM) previously received dapagliflozin and metformin (DAPA/MET) combination....
9.
Choi Y, Kim M, Lee J, Kwak M, Jeon M, Kim T, et al.
Endocrinol Metab (Seoul)
. 2023 Sep;
38(5):588-595.
PMID: 37679950
Backgruound: Thyroid cancer mortality has been largely overlooked as relatively stable given the large gap between thyroid cancer incidence and mortality. This study evaluated long-term trends in age-standardized mortality rates...
10.
Lee B, Min K, Hong E, Ku B, Kang J, Chon S, et al.
Endocrinol Metab (Seoul)
. 2023 Jul;
38(3):328-337.
PMID: 37408283
Backgruound: This study evaluated the efficacy and safety of add-on gemigliptin in patients with type 2 diabetes mellitus (T2DM) who had inadequate glycemic control with metformin and dapagliflozin. Methods: In...